Dietrich D, Beck H, Kral T, Clusmann H, Elger C E, Schramm J
Department of Neurosurgery, University of Bonn Medical Center, Germany.
Brain Res. 1997 Sep 5;767(2):220-7. doi: 10.1016/s0006-8993(97)00579-9.
Metabotropic glutamate receptors (mGluRs) have emerged as an interesting family of eight different receptor subtypes that can be divided into three groups according to their pharmacology and sequence similarity. In the present study, the specific mGluR agonists (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid ((1S,3R)-ACPD) and L(+)-2-amino-4-phosphonobutyric acid (L-AP4) depressed field excitatory postsynaptic potentials (fEPSPs) in the rat dentate gyrus evoked by perforant path stimulation in a concentration-dependent, rapid and reversible manner (EC50: L-AP4 5.9 +/- 1.6 microM, (1S,3R)-ACPD 80 +/- 34 microM). In a 'paired-pulse' stimulation protocol, the first fEPSP showed a stronger reduction, resulting in 'paired-pulse' facilitation. The effects of L-AP4 but not of (1S,3R)-ACPD could be antagonized by the group III mGluR antagonists (S)-2-amino-2-methyl-4-phosphonobutanoic acid (MAP4) and (RS)-alpha-methyl-4-phosphonophenylglycine (MPPG). Moreover, (1S,3R)-ACPD was still potently depressing fEPSPs after preperfusion of near saturating concentrations of L-AP4. Together, the results suggest that both substances act on different mGluRs. The effects of (1S,3R)-ACPD could not be further differentiated by selective group I or group II mGluR agonists. Although (2S,1'S,2'S)-2-carboxycyclopropylglycine (L-CCG-I) blocked fEPSPs at concentrations >> 1 microM, these effects, as well as L-AP4 effects, were potently antagonized by MAP4. This suggests that mGluR8 might be responsible for the actions of L-AP4 and L-CCG-I. The two different mGluRs showed a distinct distribution when fEPSPs were recorded simultaneously in the outer and middle molecular layer (OML/MML): The L-AP4 sensitive receptor, possibly mGluR8, seems to be located in the OML while (1S,3R)-ACPD showed its main effect in the MML.
代谢型谷氨酸受体(mGluRs)已成为一个有趣的受体家族,包含8种不同的受体亚型,根据其药理学特性和序列相似性可分为三组。在本研究中,特异性mGluR激动剂(1S,3R)-1-氨基环戊烷-1,3-二羧酸((1S,3R)-ACPD)和L(+)-2-氨基-4-膦酰丁酸(L-AP4)以浓度依赖性、快速且可逆的方式(半数有效浓度:L-AP4为5.9±1.6微摩尔,(1S,3R)-ACPD为80±34微摩尔)抑制大鼠齿状回中由穿通通路刺激诱发的场兴奋性突触后电位(fEPSPs)。在“配对脉冲”刺激方案中,第一个fEPSP显示出更强的降低,导致“配对脉冲”易化。L-AP4的作用可被III组mGluR拮抗剂(S)-2-氨基-2-甲基-4-膦酰丁酸(MAP4)和(RS)-α-甲基-4-膦酰苯甘氨酸(MPPG)拮抗,但(1S,3R)-ACPD的作用不能被拮抗。此外,在预先灌注接近饱和浓度的L-AP4后,(1S,3R)-ACPD仍能有效抑制fEPSPs。总之,结果表明这两种物质作用于不同的mGluRs。(1S,3R)-ACPD的作用不能通过选择性I组或II组mGluR激动剂进一步区分。尽管(2S,1'S,2'S)-2-羧基环丙基甘氨酸(L-CCG-I)在浓度远高于1微摩尔时能阻断fEPSPs,但这些作用以及L-AP4的作用均被MAP4有效拮抗。这表明mGluR8可能是L-AP4和L-CCG-I发挥作用的原因。当同时在外分子层和中分子层(OML/MML)记录fEPSPs时,这两种不同的mGluRs表现出不同的分布:对L-AP4敏感的受体,可能是mGluR8,似乎位于OML,而(1S,3R)-ACPD的主要作用在MML。